| A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder RWY Lee, MJ Corley, A Pang, G Arakaki, L Abbott, M Nishimoto, ... Physiology & behavior 188, 205-211, 2018 | 141 | 2018 |
| Psoriasis risk factors and triggers EB Lee, KK Wu, MP Lee, T Bhutani, JJ Wu Cutis 102 (5S), 18-20, 2018 | 92 | 2018 |
| Psoriasis and co-morbidity A Mina, T Tsen-Fang Acta dermato-venereologica 100 (3), 2020 | 78 | 2020 |
| Psoriasis-associated cutaneous pain: etiology, assessment, impact, and management DJ Pithadia, KA Reynolds, EB Lee, JJ Wu Journal of Dermatological Treatment, 2018 | 39 | 2018 |
| A systematic review of treatment strategies for erythrodermic psoriasis KA Reynolds, DJ Pithadia, EB Lee, W Liao, JJ Wu Journal of Dermatological Treatment 32 (1), 49-55, 2021 | 37 | 2021 |
| Treatments for inverse psoriasis: a systematic review KA Reynolds, DJ Pithadia, EB Lee, JJ Wu Journal of Dermatological Treatment, 2019 | 34 | 2019 |
| Systematic review of anti-drug antibodies of IL-17 inhibitors for psoriasis LW Thomas, EB Lee, JJ Wu Journal of Dermatological Treatment 30 (2), 110-116, 2019 | 32 | 2019 |
| Treatment of prurigo pigmentosa with diet modification: a medical case study M Wong, E Lee, Y Wu, R Lee Hawai'i Journal of Medicine & Public Health 77 (5), 114, 2018 | 29 | 2018 |
| Emerging therapies in psoriasis: a systematic review EB Lee, M Amin, T Bhutani, JJ Wu Cutis 101 (3), 5-9, 2018 | 25 | 2018 |
| A cross-sectional study of YouTube videos as a source of patient information about topical psoriasis therapies DJ Pithadia, KA Reynolds, EB Lee, JJ Wu Journal of Dermatological Treatment, 2019 | 23 | 2019 |
| Treatment of psoriasis with crisaborole EB Lee, MG Lebwohl, JJ Wu Journal of Dermatological Treatment 30 (2), 156-157, 2019 | 23 | 2019 |
| Adverse events associated with apremilast use and withdrawal for psoriasis in a real‐world setting. EB Lee, M Amin, A Egeberg, JJ Wu Journal of the European Academy of Dermatology & Venereology 32 (10), 2018 | 23 | 2018 |
| Safety and effectiveness of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis KA Reynolds, DJ Pithadia, EB Lee, W Liao, JJ Wu American Journal of Clinical Dermatology 21, 483-491, 2020 | 22 | 2020 |
| Drug survival of apremilast in patients treated for psoriasis in a real-world setting EB Lee, M Amin, JJ Wu Journal of the American Academy of Dermatology 79 (4), 760-761, 2018 | 22 | 2018 |
| Drug survival of guselkumab for psoriasis in a real-world setting: a single-center retrospective chart review EB Lee, KA Reynolds, DJ Pithadia, A Egeberg, JJ Wu Journal of Dermatological Treatment 31 (4), 342-343, 2020 | 21 | 2020 |
| Tildrakizumab in the treatment of psoriasis: latest evidence and place in therapy DJ Pithadia, KA Reynolds, EB Lee, W Liao, JJ Wu Therapeutic Advances in Chronic Disease 10, 2040622319865658, 2019 | 20 | 2019 |
| Risk of herpes zoster with IL-17 inhibitor therapy for psoriasis and other inflammatory conditions KK Wu, MP Lee, EB Lee, JJ Wu Journal of Dermatological Treatment, 2019 | 19 | 2019 |
| Drug survival of secukinumab for psoriasis in a real-world setting EB Lee, M Amin, A Egeberg, JJ Wu Journal of Dermatological Treatment 30 (2), 150-151, 2019 | 19 | 2019 |
| What is new in occupational allergic contact dermatitis in the year of the COVID pandemic? EB Lee, M Lobl, A Ford, V DeLeo, BL Adler, A Wysong Current allergy and asthma reports 21, 1-14, 2021 | 17 | 2021 |
| Rates of latent tuberculosis infection in patients treated with TNF inhibitors for psoriasis: a retrospective chart review EB Lee, M Amin, J Man, A Egeberg, JJ Wu Journal of Dermatological Treatment 29 (7), 671-675, 2018 | 16 | 2018 |
